Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer.
Planchard D, Wolf J, Solomon B, Sebastian M, Wermke M, Heist RS, Sun JM, Min Kim T, Reguart N, Sanmamed MF, Felip E, Garrido P, Santoro A, Bootle D, Couillebault XM, Gaur A, Mueller C, Poggio T, Yang J, Moschetta M, Dooms C. Planchard D, et al. Among authors: sebastian m. Lung Cancer. 2024 Nov;197:107964. doi: 10.1016/j.lungcan.2024.107964. Epub 2024 Sep 26. Lung Cancer. 2024. PMID: 39383771 Clinical Trial.
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.
Soria JC, Felip E, Cobo M, Lu S, Syrigos K, Lee KH, Göker E, Georgoulias V, Li W, Isla D, Guclu SZ, Morabito A, Min YJ, Ardizzoni A, Gadgeel SM, Wang B, Chand VK, Goss GD; LUX-Lung 8 Investigators. Soria JC, et al. Lancet Oncol. 2015 Aug;16(8):897-907. doi: 10.1016/S1470-2045(15)00006-6. Epub 2015 Jul 5. Lancet Oncol. 2015. PMID: 26156651 Clinical Trial.
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
Garassino MC, Cho BC, Kim JH, Mazières J, Vansteenkiste J, Lena H, Corral Jaime J, Gray JE, Powderly J, Chouaid C, Bidoli P, Wheatley-Price P, Park K, Soo RA, Huang Y, Wadsworth C, Dennis PA, Rizvi NA; ATLANTIC Investigators. Garassino MC, et al. Lancet Oncol. 2018 Apr;19(4):521-536. doi: 10.1016/S1470-2045(18)30144-X. Epub 2018 Mar 12. Lancet Oncol. 2018. PMID: 29545095 Free PMC article. Clinical Trial.
Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors.
Heigener DF, Schumann C, Sebastian M, Sadjadian P, Stehle I, Märten A, Lüers A, Griesinger F, Scheffler M; Afatinib Compassionate Use Consortium (ACUC). Heigener DF, et al. Among authors: sebastian m. Oncologist. 2015 Oct;20(10):1167-74. doi: 10.1634/theoncologist.2015-0073. Epub 2015 Sep 9. Oncologist. 2015. PMID: 26354527 Free PMC article.
Longitudinal Analyses of Circulating Tumor DNA for the Detection of EGFR Mutation-Positive Advanced NSCLC Progression During Treatment: Data From FLAURA and AURA3.
Gray JE, Markovets A, Reungwetwattana T, Majem M, Nogami N, Peled N, Lee JS, Cho BC, Chewaskulyong B, John T, Han JY, Sebastian M, Todd A, Rukazenkov Y, Barrett C, Chmielecki J, Lee SM, Ramalingam SS, Hartmaier R. Gray JE, et al. Among authors: sebastian m. J Thorac Oncol. 2024 Nov;19(11):1525-1538. doi: 10.1016/j.jtho.2024.07.008. Epub 2024 Jul 17. J Thorac Oncol. 2024. PMID: 39029876 Free article. Clinical Trial.
The analysis of the pulmonary domain involvement in Sjögren's disease.
Madej M, Proc K, Wawryka P, Morgiel E, Sebastian M, Wiland P, Sebastian A. Madej M, et al. Among authors: sebastian m. Ther Adv Musculoskelet Dis. 2024 Dec 16;16:1759720X241305218. doi: 10.1177/1759720X241305218. eCollection 2024. Ther Adv Musculoskelet Dis. 2024. PMID: 39691174 Free PMC article.
Performance of Lung Ultrasound as a Screening Tool for Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: a Multicenter Study.
Maria O, Eirini V, Sébastien O, Marwin G, Soledad DM, Adrian G, Pierre-Antoine J, Chiara B, Nestor A, Christos S, Maricel DM, Paola O, Alan QR, Marie-Pierre D, Barbara PC, Emilce S, Prodromos S, Nicolas LS, Marcos R, Sebastian M, Katerina A. Maria O, et al. Among authors: sebastian m. Chest. 2024 Dec 13:S0012-3692(24)05622-8. doi: 10.1016/j.chest.2024.11.038. Online ahead of print. Chest. 2024. PMID: 39675519
New particle formation from isoprene under upper-tropospheric conditions.
Shen J, Russell DM, DeVivo J, Kunkler F, Baalbaki R, Mentler B, Scholz W, Yu W, Caudillo-Plath L, Sommer E, Ahongshangbam E, Alfaouri D, Almeida J, Amorim A, Beck LJ, Beckmann H, Berntheusel M, Bhattacharyya N, Canagaratna MR, Chassaing A, Cruz-Simbron R, Dada L, Duplissy J, Gordon H, Granzin M, Große Schute L, Heinritzi M, Iyer S, Klebach H, Krüger T, Kürten A, Lampimäki M, Liu L, Lopez B, Martinez M, Morawiec A, Onnela A, Peltola M, Rato P, Reza M, Richter S, Rörup B, Sebastian MK, Simon M, Surdu M, Tamme K, Thakur RC, Tomé A, Tong Y, Top J, Umo NS, Unfer G, Vettikkat L, Weissbacher J, Xenofontos C, Yang B, Zauner-Wieczorek M, Zhang J, Zheng Z, Baltensperger U, Christoudias T, Flagan RC, El Haddad I, Junninen H, Möhler O, Riipinen I, Rohner U, Schobesberger S, Volkamer R, Winkler PM, Hansel A, Lehtipalo K, Donahue NM, Lelieveld J, Harder H, Kulmala M, Worsnop DR, Kirkby J, Curtius J, He XC. Shen J, et al. Among authors: sebastian mk. Nature. 2024 Dec;636(8041):115-123. doi: 10.1038/s41586-024-08196-0. Epub 2024 Dec 4. Nature. 2024. PMID: 39633196 Free PMC article.
679 results